Tina Aswani-Omprakash, MPH
@ownyourcrohns
#IBD #Ostomy Patient Advocate • Senior Director, Strategic Partnerships @sommerconsults @theinsighters_ • President @southasianibd @ibdesis
ID:2847680661
https://www.ownyourcrohns.com 28-10-2014 04:02:30
21,7K Tweets
5,5K Followers
2,4K Following
Happy #PrideMonth ! In June we are spotlighting LGBTQ+ IBD journeys & addressing topics including: restroom access, sexuality, and health disparities.
Join our IBD support groups:
Gay & Bisexual Men:
bit.ly/3qicxEH
Lesbian & Bisexual Women:
bit.ly/3WyBFmR
Tina Aswani-Omprakash, MPH Thanks so much! I owe you a text, too! The last few weeks have been a lot, but I had the most wonderful time at the DDW/SAIA event. You did an incredible job putting together such a fabulous event. Huge kudos to you and all the team members. Was such a bright spot in my week!
🔬News from #STARConsortium #WeTheFibrosisLab 🔬 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice Miguel Regueiro Joseph Sleiman, MD Christina Ha MD nature.com/articles/s4157…
a month late but still on time, a moving conversation with Tina Aswani-Omprakash, MPH and Dr. Parikh. South Asian IBD Alliance (SAIA)
Guidance on diet in IBD in Gastroenterology American Gastroenterological Association (AGA) by my friend Jana G Hashash, MD, MSc 👇🏾
4 points
▶️Mediterranean diet = winner
⏺️we have such little data on diet and IBD
⏺️we have even less data on adherence to diet!
✅What’s your advice to patients?
pubmed.ncbi.nlm.nih.gov/38276922/
#TGIF . Enrolling healthy #Crohnsdisease patients, age 18 and older. See below for trial at Johns Hopkins Gastroenterology & Hepatology Johns Hopkins IBD ! Let’s advance science together! #IBD
I loved this podcast💜🙏 It’s so brave how you open up and share your journey Tina Aswani-Omprakash, MPH! Your dedication to breaking the stigma and to helping the IBD Community especially those who struggle the most is something that is truly inspiring! podcasts.apple.com/us/podcast/the…
Not only US insurers: U.S. FDA EU Medicines Agency and national regulators, and ourselves in our guidelines based on old, still remaining in some brains, currently surpassed concepts. “Advanced” should be “conventional” for most patients PROFILE Crohn's Trial GETECCU Time to forget 1997 concepts
According to data 📈 from #DDW2024 (Digestive Disease Week):
Once-daily #etrasimod 1 mg and 2 mg 💊 was well-tolerated and sustained improvements in histological and endoscopic features of #EoE , as well as patient symptoms, through 5️⃣2️⃣ weeks of treatment.
🔽
healio.com/news/gastroent…
Tune in to Cleveland Clinic MD Cleveland Clinic Florida Mayo Clinic Florida General Surgery Program #SurgeryLive on 5/31/24 to hear Drs. @DavidRRosenMD, Luca Stocchi MD,MBA, and Kevin Hancock discuss, “Stricturing Crohn's Disease”. bit.ly/surgeryliveCCF pwd is surgerylive Miguel Regueiro David Rosen Steven D Wexner MD, PhD
👉🏽Inaugural Cleveland Clinic Inflammatory Bowel Diseases Global Multidisciplinary Case Conference led by Stefan Holubar MD MS 👈🏿 We are a 🌎 organization, working together across borders to improve patients’ lives. #ProgramForGlobalTranslationalIBD Miguel Regueiro Beri Ridgeway, MD Taha Qazi
#AAPIHeritageMonth Spotlight: Tina Aswani-Omprakash, MPH
Tina is recognized as a fierce IBD patient leader, advocate for IBD research, and powerful voice in the South Asian IBD community through the South Asian IBD Alliance (SAIA).
Read more about Tina ➡️ bit.ly/ACG-AAPI-Month…
Tina Aswani-Omprakash, MPH